Insomnia Treatment Market
Insomnia Treatment Market Study by OTC Drugs and Prescription Drugs Sold through Hospital Pharmacies, Retail Pharmacies, e-Commerce, Drug Stores, and Hypermarkets 2024 to 2034
Analysis of Insomnia Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Insomnia Treatment Market Overview (2024 to 2034)
The global insomnia treatment market is expected to be worth US$ 6,886.1 million in 2024. The market is anticipated to expand at a CAGR of 5.2% from 2024 to 2034. The market is predicted to reach US$ 11,385.5 million in 2034. Increasing awareness and understanding of the condition among patients and healthcare professionals is one of the key drivers of the insomnia treatment industry.
As more people come to recognize the impact that insomnia has on their daily lives, they are seeking out treatments to help manage their symptoms. Additionally, advances in medical research and technology have led to the development of more effective and targeted treatments for insomnia. This has allowed healthcare providers to offer patients a wider range of options for managing their condition, from medication to behavioral therapies.
The changes in lifestyle and work patterns have contributed to the rise of insomnia, as many people find themselves struggling to balance their responsibilities with the need for restful sleep. As such, there is a growing need for effective and accessible treatments to help people manage their insomnia and improve their overall quality of life.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2024E) | US$ 6,886.1 million |
| Forecasted Market Value (2034F) | US$ 11,385.5 million |
| Global Market Growth Rate (2024 to 2034) | 5.2% CAGR |
| OTC Drugs Growth Rate (2024 to 2034) | 5.4% CAGR |
| North America Market Share (2024) | 34.3% |
| East Asia Market Share (2024) | 16.5% |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors Have Contributed to An Increase in Global Demand for Insomnia Treatment?
“Increasing Prevalence of Sleep Disorders Is Expected to Drive the Growth of the Market”
Due to the rising prevalence of insomnia, the market for insomnia treatment is expected to grow significantly in the coming years. This growth is attributed to the increasing awareness about the condition and its treatment options, as well as the development of more effective and safer drugs for insomnia. Additionally, the growing demand for non-pharmacological treatments, such as cognitive behavioral therapy (CBT) and relaxation techniques, is driving the market growth. With these factors in play, the insomnia treatment market is projected to experience substantial growth during the forecast period.
“The Demand for Over-the-counter Therapeutics Is Projected to Create Attractive Prospects for Insomnia Treatment.”
The increasing demand for over-the-counter (OTC) insomnia therapeutics is expected to drive the market's growth for various reasons. The prevalence of insomnia is increasing globally, leading to a rise in demand for its treatment. OTC drugs are easily available and do not require a prescription, making them more accessible to people suffering from sleep disorders. Additionally, OTC drugs are cost-effective as compared to prescription drugs, which is another factor driving their demand. Lastly, the increasing awareness among consumers about the benefits of OTC sleep aids is contributing to the growth of the market.
Which Factor is a Barrier to the Growth of Insomnia Treatment Demand?
“Some Medication Side Effects of Insomnia Treatment Is Expected to Hamper the Market Growth for The Forecast Period”
Long-term consumption of certain medications used to treat chronic diseases, such as high blood pressure, diabetes, and depression, causes side effects that interfere with the treatment of insomnia. For instance, some medications cause drowsiness or fatigue, while others are predicted to increase wakefulness and make it difficult to fall asleep. As a result, patients need to adjust their medication regimen or seek alternative treatments to manage their insomnia. This is having an impact on the market for insomnia treatments, as some patients choose to forego traditional pharmaceuticals in favor of non-medical treatments or natural remedies.
Apart from the side effects of medication used to treat chronic diseases, other factors hamper the insomnia treatment market. These include the growing popularity of non-pharmacological treatments, such as cognitive behavioral therapy and mindfulness meditation, which are effective in treating insomnia without the risk of side effects associated with medication.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
North America is estimated to account for a 34.3% share of the global market in 2024. From 2024 to 2034, the market in North America is expected to rise at a moderate CAGR of 4.7%, with a share of 32.8% by 2034.
East Asia's insomnia treatment industry is anticipated to hold a share of 16.5% in 2024. During the projection period, East Asia's market is projected to rise at a steady 6.9% CAGR, with the region retaining 19.4% of the share through 2034.
What Factors Determine the Continued Growth of the United States Insomnia Treatment Market?
“Increasing Rate of Sleep Disorders in the United States are Expected to Drive Market Progress”
The value of the insomnia treatment industry in the United States for 2024 is estimated to be US$ 2,039 million. Over the forecast period, the market is expected to register an encouraging CAGR of 4.5% in the country, reaching a value of US$ 3,154 million by 2034.
With the increase in cases of sleeping disorders, there has been a rise in demand for insomnia treatment in the country. Insomnia is a common sleep disorder that affects millions of people in the United States. It is characterized by difficulty falling or staying asleep, which leads to daytime fatigue, irritability, and decreased productivity.
Some of the commonly used treatment options for insomnia include medication, cognitive-behavioral therapy, relaxation techniques, and sleep hygiene education. While medication is the most widely used treatment option, there is a growing trend towards non-pharmacologic treatments, such as cognitive-behavioral therapy, due to concerns about the potential side effects of medication.
Why is China considered a Major Market for the Insomnia Treatment Market?
“ Increasing Number of Geriatric Population and Lifestyle Changes in China”
Insomnia is a common problem in China, and as the population ages and lifestyles change, the demand for insomnia treatments is expected to grow. The adoption of generic drugs drive the market for insomnia treatments in China due to the large number of manufacturers in the country. However, there is a growing demand for more innovative and effective treatments, particularly among younger and more affluent consumers. In recent years, there has been a trend towards the development of personalized insomnia treatments in China. These treatments are tailored to the individual needs of each patient and include a combination of medication, behavioral therapy, and lifestyle changes.
Category-wise Insights
Based on drug type, the OTC drugs segment is expected to account for 69.6% of the market share in 2024.
Why do OTC drugs dominate the market for Insomnia Treatment?
“Increasing Demand for Over the Counter (OTC) Drugs Owing to Its Advantages Such as Easily Accessible and There Is No Requirement for Any Type Prescription”
The OTC drugs segment is expected to contribute 69.6% of the market share by drug type in 2024. The OTC drugs are anticipated to witness a rise in demand for insomnia treatment at a CAGR of 5.4% through 2034. The OTC drugs segment in the insomnia treatment market has been growing due to several factors. The OTC drugs are easily accessible and do not require a prescription, making them a convenient option for consumers. Additionally, OTC drugs are typically less expensive than prescription drugs, which makes them an attractive option for those looking for more affordable options for treating their insomnia. Many OTC drugs contain natural ingredients such as melatonin, which is believed to help regulate sleep patterns. This has allowed the growth of the OTC Drugs segment in the insomnia treatment market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Landscape
The key players in the insomnia treatment market include Paratek Pharmaceuticals, Inc., Vanda Pharmaceuticals Inc., Sanofi S.A, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Teva Pharmaceutical Industries Limited, Viatris Inc., Takeda Pharmaceutical Company Limited, Pfizer Inc.
Some of the key players in the insomnia treatment industry include pharmaceutical companies. Several startups specialize in developing alternative remedies and supplements for insomnia, such as melatonin and valerian root. With the increasing prevalence of insomnia and related conditions, competition is likely to rise during the forecast period.
In 2021, HoneyNaps revealed plans to launch a digital therapy business to treat insomnia, in addition to monitoring, analyzing, and diagnosing inter-sleep bio-signals. SOMNUM, an artificial intelligence (AI)-based program for diagnosing sleep problems, My SOMNUM, a non-contact sleep analysis and coaching solution, and SOMNUM Medella, a digital treatment for insomnia, comprise the platform.
Segmentation of Insomnia Treatment Market Research
-
By Drug Type:
- OTC Drugs
- Prescription Drugs
-
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- eCommerce
- Drug Stores & Hypermarkets
-
By Region:
- North America
- Europe
- Latin America
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Treatment Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Treatment Type, 2024 to 2034 5.3.1. Drug 5.3.1.1. Benzodiazepines 5.3.1.2. Nonbenzodiazepines 5.3.1.3. Orexin Antagonist 5.3.1.4. Other Drugs 5.3.2. Devices 5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Treatment Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034 6.3.1. Hospital Pharmacies 6.3.2. Retail Pharmacies 6.3.3. Other Distribution Channels 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Treatment Type 8.2.3. By Distribution Channel 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Treatment Type 8.3.3. By Distribution Channel 8.4. Key Takeaways 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Treatment Type 9.2.3. By Distribution Channel 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Treatment Type 9.3.3. By Distribution Channel 9.4. Key Takeaways 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Treatment Type 10.2.3. By Distribution Channel 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Treatment Type 10.3.3. By Distribution Channel 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Treatment Type 11.2.3. By Distribution Channel 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Treatment Type 11.3.3. By Distribution Channel 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Treatment Type 12.2.3. By Distribution Channel 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Treatment Type 12.3.3. By Distribution Channel 12.4. Key Takeaways 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Treatment Type 13.2.3. By Distribution Channel 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Treatment Type 13.3.3. By Distribution Channel 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Treatment Type 14.2.3. By Distribution Channel 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Treatment Type 14.3.3. By Distribution Channel 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2023 15.1.2.1. By Treatment Type 15.1.2.2. By Distribution Channel 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2023 15.2.2.1. By Treatment Type 15.2.2.2. By Distribution Channel 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2023 15.3.2.1. By Treatment Type 15.3.2.2. By Distribution Channel 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2023 15.4.2.1. By Treatment Type 15.4.2.2. By Distribution Channel 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2023 15.5.2.1. By Treatment Type 15.5.2.2. By Distribution Channel 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2023 15.6.2.1. By Treatment Type 15.6.2.2. By Distribution Channel 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2023 15.7.2.1. By Treatment Type 15.7.2.2. By Distribution Channel 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2023 15.8.2.1. By Treatment Type 15.8.2.2. By Distribution Channel 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2023 15.9.2.1. By Treatment Type 15.9.2.2. By Distribution Channel 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2023 15.10.2.1. By Treatment Type 15.10.2.2. By Distribution Channel 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2023 15.11.2.1. By Treatment Type 15.11.2.2. By Distribution Channel 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2023 15.12.2.1. By Treatment Type 15.12.2.2. By Distribution Channel 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2023 15.13.2.1. By Treatment Type 15.13.2.2. By Distribution Channel 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2023 15.14.2.1. By Treatment Type 15.14.2.2. By Distribution Channel 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2023 15.15.2.1. By Treatment Type 15.15.2.2. By Distribution Channel 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2023 15.16.2.1. By Treatment Type 15.16.2.2. By Distribution Channel 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2023 15.17.2.1. By Treatment Type 15.17.2.2. By Distribution Channel 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2023 15.18.2.1. By Treatment Type 15.18.2.2. By Distribution Channel 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2023 15.19.2.1. By Treatment Type 15.19.2.2. By Distribution Channel 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2023 15.20.2.1. By Treatment Type 15.20.2.2. By Distribution Channel 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2023 15.21.2.1. By Treatment Type 15.21.2.2. By Distribution Channel 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2023 15.22.2.1. By Treatment Type 15.22.2.2. By Distribution Channel 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2023 15.23.2.1. By Treatment Type 15.23.2.2. By Distribution Channel 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Treatment Type 16.3.3. By Distribution Channel 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Merck & Co. 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Ebb Therapeutics 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Paratek Pharmaceuticals Inc. 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Pfizer Inc. 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Sanofi SA 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Electromedical Products International Inc. 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Takeda Pharmaceutical Company Ltd 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Cerêve Inc. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Innovative Neurological Devices 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Eisai Co. Ltd 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Meda Consumer Healthcare 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 4: Global Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 5: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 6: Global Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 8: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 9: North America Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 10: North America Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 11: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 12: North America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 15: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 16: Latin America Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 17: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 18: Latin America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 20: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 21: Western Europe Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 22: Western Europe Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 23: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 24: Western Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Eastern Europe Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 28: Eastern Europe Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 29: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 30: Eastern Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 32: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 34: South Asia and Pacific Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 36: South Asia and Pacific Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 39: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 40: East Asia Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 41: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 42: East Asia Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 44: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Treatment Type, 2019 to 2034
Table 46: Middle East and Africa Market Volume (Units) Forecast by Treatment Type, 2019 to 2034
Table 47: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 48: Middle East and Africa Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 5: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 9: Global Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 10: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 11: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 12: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 13: Global Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 14: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 15: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 16: Global Market Attractiveness by Treatment Type, 2024 to 2034
Figure 17: Global Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 18: Global Market Attractiveness by Region, 2024 to 2034
Figure 19: North America Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 20: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 22: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 23: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 26: North America Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 27: North America Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 28: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 29: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 30: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 31: North America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 34: North America Market Attractiveness by Treatment Type, 2024 to 2034
Figure 35: North America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 36: North America Market Attractiveness by Country, 2024 to 2034
Figure 37: Latin America Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 38: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 39: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 41: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 45: Latin America Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 49: Latin America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 50: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 52: Latin America Market Attractiveness by Treatment Type, 2024 to 2034
Figure 53: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 55: Western Europe Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 56: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 57: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 59: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 63: Western Europe Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 66: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 67: Western Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 68: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 70: Western Europe Market Attractiveness by Treatment Type, 2024 to 2034
Figure 71: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 73: Eastern Europe Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 74: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 77: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 81: Eastern Europe Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 85: Eastern Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 88: Eastern Europe Market Attractiveness by Treatment Type, 2024 to 2034
Figure 89: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 91: South Asia and Pacific Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 92: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 95: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 99: South Asia and Pacific Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 103: South Asia and Pacific Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 106: South Asia and Pacific Market Attractiveness by Treatment Type, 2024 to 2034
Figure 107: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 109: East Asia Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 110: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 111: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 113: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 116: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 117: East Asia Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 118: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 120: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 121: East Asia Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 122: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 123: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 124: East Asia Market Attractiveness by Treatment Type, 2024 to 2034
Figure 125: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 127: Middle East and Africa Market Value (US$ Million) by Treatment Type, 2024 to 2034
Figure 128: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 131: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Treatment Type, 2019 to 2034
Figure 135: Middle East and Africa Market Volume (Units) Analysis by Treatment Type, 2019 to 2034
Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment Type, 2024 to 2034
Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment Type, 2024 to 2034
Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 139: Middle East and Africa Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034
Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 142: Middle East and Africa Market Attractiveness by Treatment Type, 2024 to 2034
Figure 143: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
Which is the Leading Drug Type in the Insomnia Treatment market?
The OTC drugs segment is the leading drug type, with an expected market share of 69.6% in 2024.
What is the Market Outlook for the Insomnia Treatment?
Insomnia treatment sales outlook is likely to be valued at US$ 6,886.1 million in 2024.
What is the Market Forecast for Insomnia Treatment over the Next Decade?
Demand for insomnia treatment is projected to reach US$ 11,385.5 million by the end of 2034.
What is the growth projection for Insomnia Treatment adoption?
The demand for insomnia treatment is projected to rise at a CAGR of 5.2% through 2034.
How fast is the North America market expected to grow?
The East Asia insomnia treatment market is forecasted to expand at a CAGR of 6.9% through 2034.
Insomnia Treatment Market